DiscoverOncology On The GoS2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer
S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

Update: 2022-04-05
Share

Description

As part of its Between the Lines™ video series, CancerNetwork® spoke with Liliana Bustamante, MD, hematologist and medical oncologist at Florida Cancer Specialists in Fort Myers, Florida and Richard Kim, MD, service chief of Medical Gastrointestinal Oncology and senior member in the Gastrointestinal Oncology Department at the Moffitt Cancer Center in Tampa, Florida, about the prognostic potential of circulating tumor DNA (ctDNA) as a biomarker for patients with oligometastatic colorectal cancer.



In the video series, Bustamante and Kim discussed the following:












To watch more videos in CancerNetwork®’s Between the Lines™ series, visit cancernetwork.com/between-the-lines.



Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify or anywhere podcasts are available.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

CancerNetwork